STOCK TITAN

Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Paragon 28 (NYSE: FNA), a specialized medical device company focused on foot and ankle orthopedics, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's Chairman and CEO Albert DaCosta, along with CFO & EVP of Supply Chain Operations Chadi Chahine, will deliver a presentation on Monday, January 13, 2025, at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.

Interested parties can access the presentation through a live webcast, and an archived recording will be made available on the investor relations section of Paragon 28's website at ir.paragon28.com.

Paragon 28 (NYSE: FNA), un'azienda specializzata nella produzione di dispositivi medici focalizzati sull'ortopedia del piede e della caviglia, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il presidente e CEO dell'azienda Albert DaCosta, insieme al CFO e EVP delle Operazioni della Supply Chain Chadi Chahine, presenteranno venerdì 13 gennaio 2025, alle 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.

Le parti interessate possono accedere alla presentazione tramite un webcast in diretta, e una registrazione archiviata sarà resa disponibile nella sezione relazioni con gli investitori del sito web di Paragon 28 su ir.paragon28.com.

Paragon 28 (NYSE: FNA), una empresa de dispositivos médicos especializada en ortopedia del pie y el tobillo, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. El presidente y CEO de la empresa, Albert DaCosta, junto con el CFO y EVP de Operaciones de la Cadena de Suministro, Chadi Chahine, ofrecerán una presentación el lunes 13 de enero de 2025, a las 7:30 a.m. Hora del Pacífico / 8:30 a.m. Hora de la Montaña.

Las partes interesadas pueden acceder a la presentación a través de una transmisión en vivo, y se pondrá a disposición una grabación archivada en la sección de relaciones con los inversores del sitio web de Paragon 28 en ir.paragon28.com.

파라곤 28 (NYSE: FNA), 발과 발목 정형외과에 중점을 둔 전문 의료 기기 회사가 43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 회장 겸 CEO인 알버트 다코스타와 CFO 및 공급망 운영 부사장인 차디 샤힌이 2025년 1월 13일 월요일, 태평양 표준시 기준 오전 7시 30분 / 산악 표준시 기준 오전 8시 30분에 프레젠테이션을 진행할 예정입니다.

관심 있는 당사자는 라이브 웹캐스트를 통해 프레젠테이션에 접근할 수 있으며, 아카이브된 녹화는 파라곤 28의 웹사이트 투자자 관계 섹션인 ir.paragon28.com에 제공될 예정입니다.

Paragon 28 (NYSE: FNA), une entreprise spécialisée dans les dispositifs médicaux axée sur l'orthopédie du pied et de la cheville, a annoncé sa participation à la 43ème Conférence Annuelle de Soins de Santé J.P. Morgan. Le président-directeur général de l'entreprise, Albert DaCosta, ainsi que le directeur financier et vice-président exécutif des opérations de la chaîne d'approvisionnement, Chadi Chahine, présenteront le lundi 13 janvier 2025, à 7h30 heure du Pacifique / 8h30 heure des montagnes.

Les parties intéressées peuvent accéder à la présentation via un webcast en direct, et un enregistrement archivé sera rendu disponible dans la section des relations avec les investisseurs du site web de Paragon 28 à ir.paragon28.com.

Paragon 28 (NYSE: FNA), ein spezialisiertes Medizintechnikunternehmen, das sich auf Fuß- und Sprunggelenkorthopädie konzentriert, hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Der Vorsitzende und CEO des Unternehmens, Albert DaCosta, zusammen mit dem CFO und EVP der Supply Chain Operations, Chadi Chahine, werden am Montag, den 13. Januar 2025, um 7:30 Uhr Pacific Time / 8:30 Uhr Mountain Time eine Präsentation halten.

Interessierte Parteien können die Präsentation über einen Live-Webcast abrufen, und eine archivierte Aufzeichnung wird im Abschnitt für Investorenbeziehungen der Paragon 28-Website unter ir.paragon28.com verfügbar gemacht.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.

A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Matt Brinckman

Senior Vice President, Strategy and Investor Relations

(720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

When is Paragon 28 (FNA) presenting at the J.P. Morgan Healthcare Conference 2025?

Paragon 28 will present at the conference on Monday, January 13, 2025, at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.

How can investors watch Paragon 28's (FNA) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast available on Paragon 28's investor relations website at ir.paragon28.com. An archived recording will also be available on the same platform.

Which Paragon 28 (FNA) executives are presenting at the 2025 J.P. Morgan Healthcare Conference?

Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the conference.

What is Paragon 28's (FNA) main business focus in the medical device industry?

Paragon 28 is a medical device company exclusively focused on the foot and ankle orthopedic market.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

866.51M
49.75M
40.58%
60.93%
4.24%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD